Overview

Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
Fluid management study in patients with type 2 diabetes and autonomic neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Rosiglitazone